# Neural Galaxy

> Neural Galaxy (also operating as Galaxy Brain Scientific) is a Beijing-based brain science company building a precision, non-invasive neuromodulation platform. Its proprietary personalized Brain Functional Sectors (pBFS) technology maps over 200 functional regions of an individual brain, then guides targeted transcranial magnetic stimulation with millimeter accuracy. Founded in 2019 by Harvard and MIT neuroscientists with serial entrepreneur Coach Wei, the company is running clinical and registration trials across depression, Parkinson's, Alzheimer's, autism and aphasia, and has raised roughly $93M to date.

- **Founded:** 2019
- **Headquarters:** Beijing, China
- **Founders:** Hesheng Liu (Co-founder & Chief Scientific Officer (Prof., formerly Harvard Medical School)), Coach Wei (Co-founder & CEO), Robert Desimone (Co-founder (Director, MIT McGovern Institute)), Guoping Feng (Co-founder (Professor, MIT))
- **Team size:** ~21 (per Apollo record); company stated plans to grow by 300-400 researchers, engineers and medical staff after Series A
- **Products:** pBFS (personalized Brain Functional Sectors), POINT Therapy, Personalized Brain Computing Platform
- **Notable:** Developed the world's first and only personalized Brain Functional Sectors (pBFS) technology, mapping 200+ individual functional regions., Released what it calls the world's first Personalized Brain Computing Platform (2020)., China NMPA clearance for its precision targeting and non-invasive TMS system.

## Products & services

- **pBFS (personalized Brain Functional Sectors)** — Proprietary technology that reliably and accurately maps over 200 functional parcellations of an individual brain, creating a personalized functional atlas to guide treatment.
- **POINT Therapy** — Personalized neuromodulation that delivers individual-level precise intervention via a non-invasive 'brain-computer interaction' approach to read, decode and write brain signals.
- **Personalized Brain Computing Platform** — Software-and-hardware system (China NMPA-cleared) for individualized precision targeting and non-invasive TMS stimulation with millimeter accuracy, letting clinicians study neural circuits at the individual level.

## Achievements

- Developed the world's first and only personalized Brain Functional Sectors (pBFS) technology, mapping 200+ individual functional regions.
- Released what it calls the world's first Personalized Brain Computing Platform (2020).
- China NMPA clearance for its precision targeting and non-invasive TMS system.
- Technology underpinned a 2026 Nature paper redefining the core brain circuit of Parkinson's disease (analysis of 800+ participants).
- Raised roughly $93M total across angel, pre-A and Series A rounds.

## Latest updates

- **2026-02** — Galaxy Brain Scientific's technology enabled a landmark Parkinson's study published in Nature identifying the somato-cognitive action network (SCAN) as a core circuit of the disease.
- **2024-2025** — Multiple pBFS-guided rTMS clinical trials for treatment-resistant depression underway (registered on ClinicalTrials.gov).
- **2021-08** — Closed $77M (CNY500M) Series A led by 3E Bioventures Capital to accelerate brain-disease detection and treatment products.

## Links

- Website: https://www.gb-scientific.com/
- LinkedIn: https://www.linkedin.com/company/neural-galaxy

---

Profile page: https://yespress.io/neural-galaxy
Published by YesPress — https://yespress.io
Last updated: 2026-06-08